Invention Grant
- Patent Title: CD33 binding agents
- Patent Title (中): CD33结合剂
-
Application No.: US14742836Application Date: 2015-06-18
-
Publication No.: US09550833B2Publication Date: 2017-01-24
- Inventor: Renate Konopitzky , Eric Borges , Paul Adam , Karl-Heinz Heider
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Atabak R. Royaee
- Priority: EP10186468 20101004
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C07K16/28
Abstract:
The present invention relates to immunotherapies that are based on myeloid cell depletion. In particular, the present invention relates to CD33 binding agents for use in such therapies, e.g. in the treatment of myeloid cell malignancies and myelodysplastic syndrome (MDS).
Public/Granted literature
- US20150284462A1 CD33 BINDING AGENTS Public/Granted day:2015-10-08
Information query
